Author

Anna Klimova

Institut Pasteur

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:DNA methylation· 1 Research Focus:drug response / drug discovery· 1 Organism:fungi (other)· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Research Focus:variant calling· 1 Assay:whole-genome sequencing· 1

Frequent Co-Authors

Alexander Arthur WurmiD· 1 shared Angela TaddeiiD· 1 shared Attila Jády· 1 shared Benjamin Christopher SchmidtiD· 1 shared Christoph E. HeiligiD· 1 shared Christoph HeiningiD· 1 shared Claudia Dagostino· 1 shared Claudia R. BalliD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alexander Arthur WurmORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

SAD-6/ATRX enables broad genome surveillance and defense in fungi

Florian Carlier, Anna Klimova, Eléonore Bouscasse, Ziyan Wang, Isabelle Loïodice, Angela Taddei, Ilkka Kronholm, Jay Dunlap, Mariette Matondo, Eugene A. Gladyshev

This paper shows that the fungal ATRX ortholog SAD-6 uses a unique histone H4 variant for genome surveillance and defense, revealing its role in various genomic regions and a repeat-induced point mutation pathway.

bioRxiv · Aug 11, 2026 · PreprintMolecular Biology

Systematic functional drug testing in patient-derived models reveals ex vivo sensitivities associated with clinical outcome in rare solid tumors

Jasmina Paluncic, Zunamys Itzell Carrero, Lilly KS Fischer, Juliana P Schulz, Dorothea Hanf, Attila Jády, Fatima GutierrezTenorio, Anna Klimova, Claudia Dagostino, Isabell Wolf, Melanie Hüther, Maximilian Werner, Parham Pourabbas Tahvildari, Sara Hrabovska, Maria G Santos, , Claudia R. Ball

This study develops an ex vivo drug sensitivity testing platform for rare solid tumors and finds that high in vitro sensitivity correlates with clinical benefit and progression-free survival.

bioRxiv · Feb 19, 2026 · PreprintCancer Biology